title: Liver transplantation: The effect of new HCV drugs on liver transplantation outcomes.
abstract: Liver transplantations for patients who are co-infected with HIV and HCV have always posed a challenge and still do, according to the results of a new study. This article discusses the factors that contribute to an increased risk of poor transplantation outcomes and how new treatment options might affect patient survival.
authors.affiliation: Centre Hépato-Biliaire, Hôpital Universitaire Paul Brousse, 12-14 Avenue Paul Vaillant Couturier, F-94800 Villejuif, France.
authors.forename: Didier
authors.initials: D
authors.lastname: Samuel
authors.affiliation: Centre Hépato-Biliaire, Hôpital Universitaire Paul Brousse, 12-14 Avenue Paul Vaillant Couturier, F-94800 Villejuif, France.
authors.forename: Jean-Charles
authors.initials: JC
authors.lastname: Duclos-Vallée
mesh_terms: D060085:Coinfection / Q000150:complications*; D058625:End Stage Liver Disease / Q000150:complications* / Q000601:surgery*; D005260:Female; D015658:HIV Infections / Q000150:complications*; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D016031:Liver Transplantation / Q000706:statistics & numerical data*; D008297:Male